Omics technologies have rapidly evolved with the unprecedented potential to shape
precision medicine. Novel omics approaches are imperative toallow rapid and accurate data …

Cardiovascular diseases (CVDs) are the number one cause of death worldwide, taking 17.9
million lives each year. The rapid, sensitive, and accurate determination of cardiac …

Molecularly imprinted polymers (MIPs) are the equivalent of natural antibodies and have
been widely used as synthetic receptors for the detection of disease biomarkers. Benefiting …

Many emerging technologies have the potential to improve health care by providing more
personalized approaches or early diagnostic methods. In this review, we cover smartphone …

Background Microfluidic devices have evolved into low-cost, simple, and powerful analytical
tool platforms. Herein, an electrochemically-based microfluidic nanobiosensor array for …

Immunoassays based on antigen–antibody specific recognition have attracted tremendous
attention as simple and rapid analytical methods. The detection sensitivity and efficiency are …

Cancer released-exosomes containing specific surface proteins have high value in tumor
diagnosis and are considered a novel liquid biopsy biomarker. However, the development of …

Alzheimer's disease (AD) is the most common neurological disease and a serious cause of
dementia, which constitutes a threat to human health. The clinical evidence has found that …

Point-of-care (POC) diagnostics in particular focuses on the timely identification of harmful
conditions close to the patients' needs. For future healthcare these diagnostics could be an …

In vitro diagnostics (IVDs) form the cornerstone of modern medicine. They are routinely
employed throughout the entire treatment pathway, from initial diagnosis through to …